PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.\', \'COBRE on Opioids and Overdose and the Department of Emergency Medicine, Rhode Island Hospital, Providence Rhode Island, USA.\', \'University of Rhode Island College of Pharmacy, Kingston, Rhode Island, USA.\', \'Oregon State University College of Pharmacy, Corvallis, Oregon, USA.\', \'Comagine Health, Portland, Oregon, USA.\', \'University of Washington, University of Washington, Seattle, Washington, USA.\', \'Washington State Pharmacy Association, Renton, Washington, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/08897077.2021.2010162
?:hasPublicationType
?:journal
  • Substance abuse
is ?:pmid of
?:pmid
?:pmid
  • 35213293
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.009
?:rankingScore_hIndex
  • 36
is ?:relation_isRelatedTo_publication of
?:title
  • Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35213293>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35213293>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all